Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

Xia, Bing, Dorsman, Josephine C, Ameziane, Najim, de Vries, Yne, Rooimans, Martin A, Sheng, Qing, Pals, Gerard, Errami, Abdellatif +6 more·2007·Nature Genetics
DOI 10.1038/ng1942

Cited by (465)

Items 101–200 of 465

  1. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway
    Sonali Bhattacharjee, Saikat Nandi · 2017 · Cell Communication and Signaling
  2. Breast cancer genes: beyond BRCA1 and BRCA2
    Ana Vega · 2013 · Frontiers in bioscience
  3. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly
    Kanchan D. Mirchandani, Ryan M. McCaffrey, Alan D. D’Andrea · 2008 · DNA repair
  4. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
    A‐Yong Cao, Juan Huang, Zhen Hu, Wenfeng Li, Zhongliang Ma, Lili Tang, Bin Zhang, Fengxi Su, Jie Zhou, Gen‐Hong Di et al. · 2008 · Breast Cancer Research and Treatment
  5. Breast Cancer Proteins PALB2 and BRCA2 Stimulate Polymerase η in Recombination-Associated DNA Synthesis at Blocked Replication Forks
    Rémi Buisson, Niraj Joshi, Joris Pauty, Ranjan Maity, Weixing Zhao, Yan Coulombe, Patrick Sung, Jean‐Yves Masson · 2014 · Cell Reports
  6. Recruitment of Fanconi Anemia and Breast Cancer Proteins to DNA Damage Sites Is Differentially Governed by Replication
    Xi Hua Shen, Huong Do, Yongjiang Li, Woo-Hyun Chung, Maria Tomasz, Johan P. de Winter, Bing Xia, Stephen Joseph Elledge, Weidong Wang, Lei Li · 2009 · Molecular Cell
  7. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair
    Justin W. C. Leung, Yucai Wang, Ka-wing Fong, Michael S.Y. Huen, Lei Li, Junjie Chen · 2012 · Proceedings of the National Academy of Sciences
  8. Heterozygous mutations in PALB2 cause DNA replication and damage response defects
    Jenni Nikkilä, Ann Christin Parplys, Katri Pylkäs, Muthiah Bose, Yanying Huo, Kerstin Borgmann, Katrin Rapakko, Pentti A. Nieminen, Bing Xia, Helmut Pospiech et al. · 2013 · Nature Communications
  9. FANCM and FAAP24 Maintain Genome Stability via Cooperative as Well as Unique Functions
    Yucai Wang, Justin W. C. Leung, Yingjun Jiang, Megan G. Lowery, Huong Do, Karen M. Vásquez, Junjie Chen, Weidong Wang, Lei Li · 2013 · Molecular Cell
  10. Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
    Tzeh Keong Foo, Marc D. Tischkowitz, Srilatha R. Simhadri, Talia Boshari, Nadia Zayed, Karly A. Burke, S H Berman, Pedro Blecua, Nadeem Riaz, Yanying Huo et al. · 2017 · Oncogene
  11. Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene
    Jung-Young Park, Elizabeth L. Virts, Anna Malgorzata Jankowska, Constanze Wiek, Mohamed Abdelhalim Othman, Sujata Chakraborty, Gail H. Vance, Fowzan Sami Alkuraya, Helmut Hanenberg, Paul R. Andreassen · 2016 · Journal of Medical Genetics
  12. Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults
    M. Schneider, Kate Chandler, Marc D. Tischkowitz, Stefan Meyer · 2014 · Clinical Genetics
  13. ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function
    Natalie Bucheimer Collins, James B. Wilson, Thomas Bush, Andrei Tomashevski, Kate J. Roberts, Nigel J. Jones, Gary M. Kupfer · 2008 · Blood
  14. MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks
    Tomohiro Hayakawa, Fan Zhang, Noriyo Hayakawa, Yasuko Ohtani, Kaori Shinmyozu, Jun‐ichi Nakayama, Paul R. Andreassen · 2010 · Journal of Cell Science
  15. Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
    Marc D. Tischkowitz, Judith Balmañà, William David Foulkes, Paul Andrew James, Joanne Yuen Yie Ngeow, Rita Katharina Schmutzler, Nicoleta C. Voian, Myra J. Wick, Douglas R. Stewart, Tuya Pal · 2021 · Genetics in Medicine
  16. PALB2: The hub of a network of tumor suppressors involved in DNA damage responses
    Jung‐Young Park, Fan Zhang, Paul R. Andreassen · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  17. Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice
    Srilatha R. Simhadri, Shaun Peterson, Dharm S. Patel, Yanying Huo, Hong Cai, Christian Bowman-Colin, Shoreh Miller, Thomas Ludwig, Shridar Ganesan, Mantu Bhaumik et al. · 2014 · Journal of Biological Chemistry
  18. Genetic subtyping of Fanconi anemia by comprehensive mutation screening
    Najim Ameziane, Abdellatif Errami, France Léveillé, Chantal Fontaine, Yne de Vries, Rosalina M.L. van Spaendonk, Johan P. de Winter, Gerard Pals, Hans Joenje · 2007 · Human Mutation
  19. Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
    Can-Bin Fang, Hua-Tao Wu, Manli Zhang, Jing Liu, Guo‐Jun Zhang · 2020 · Frontiers in Cell and Developmental Biology
  20. Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673
    Malcolm Anders Smith, Oliver A. Hampton, C. Patrick Reynolds, Min H. Kang, John M. Maris, Richard Greg Gorlick, Edward Anders Kolb, Richard B. Lock, Hernán Carol, Stephen Thomas Keir et al. · 2014 · Pediatric Blood & Cancer
  21. Inherited Mutations in Breast Cancer Genes—Risk and Response
    Andrew Y. Shuen, William D. Foulkes · 2011 · Journal of Mammary Gland Biology and Neoplasia
  22. Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice
    Daniel P. Sejas, Reena Rani, Yuhui Qiu, Xiaoling Zhang, Sara R. Fagerlie, Hiroyasu Nakano, David A. Williams, Qishen Pang · 2007 · The Journal of Immunology
  23. PALB2 (partner and localizer of BRCA2)
    Helmut Hanenberg, Paul R. Andreassen · 2018 · Atlas of Genetics and Cytogenetics in Oncology and Haematology
  24. Human Papillomavirus and the DNA Damage Response: Exploiting Host Repair Pathways for Viral Replication
    Chelsey C. Spriggs, Laimonis A. Laimins · 2017 · Viruses
  25. The Cellular Phenotype of Roberts Syndrome Fibroblasts as Revealed by Ectopic Expression of ESCO2
    Petra van der Lelij, Barbara C. Godthelp, Wouter van Zon, Djoke van Gosliga, Anneke B. Oostra, Jûrgen Steltenpool, Jan de Groot, Rik J. Scheper, Rob M.F. Wolthuis, Quinten Waisfisz et al. · 2009 · PLoS ONE
  26. DNA Repair Alterations in Children With Pediatric Malignancies: Novel Opportunities to Identify Patients at Risk for High-Grade Toxicities
    Claudia E. Rübe, Andreas Fricke, Ruth Schneider, Karin Simon, Martin Kühne, Jochen Fleckenstein, Stefan M. Graeber, Norbert M. Graf, Christian Rübe · 2010 · International Journal of Radiation Oncology*Biology*Physics
  27. The roles of DNA polymerase ζ and the Y family DNA polymerases in promoting or preventing genome instability
    Shilpy Sharma, Corey M. Helchowski, Christine E. Canman · 2012 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  28. Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network
    Roger A. Greenberg · 2008 · Chromosoma
  29. MRG15 Is a Novel PALB2-interacting Factor Involved in Homologous Recombination
    Shirley M.-H. Sy, Michael S.Y. Huen, Junjie Chen · 2009 · Journal of Biological Chemistry
  30. Role of homologous recombination in DNA interstrand crosslink repair
    John M. Hinz · 2010 · Environmental and Molecular Mutagenesis
  31. The Fanconi anemia pathway: Repairing the link between DNA damage and squamous cell carcinoma
    Lindsey E. Romick‐Rosendale, Vivian Wai Yan Lui, Jennifer Rubin Grandis, Susanne I. Wells · 2013 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  32. Fanconi anemia proteins stabilize replication forks
    Lily Chien Wang, Stacie Stone, Maureen E. Hoatlin, Jean Gautier · 2008 · DNA repair
  33. FANCI Protein Binds to DNA and Interacts with FANCD2 to Recognize Branched Structures
    Fenghua Yuan, Jimmy A. El Hokayem, Wen Zhou, Yanbin Zhang · 2009 · Journal of Biological Chemistry
  34. Genetics of pediatric renal tumors
    Brigitte Royer‐Pokora · 2012 · Pediatric Nephrology
  35. Fanconi anemia and breast cancer susceptibility meet again
    Ephrat Levy‐Lahad · 2010 · Nature Genetics
  36. Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
    Rick A.C.M. Boonen, Amélie Rodrigue, Chantal Stoepker, Wouter W. Wiegant, Bas Vroling, Milan Sharma, Magdalena B. Rother, Nandi Celosse, Maaike P.G. Vreeswijk, Fergus J. Couch et al. · 2019 · Nature Communications
  37. BRCA Gene Structure and Function in Tumor Suppression
    Conleth G. Murphy, Mary Ellen Moynahan · 2010 · The Cancer Journal
  38. Pancreatic cancer genomics
    David Kuang-Fu Chang, Sean Michael Grimmond, Andrew Victor Biankin · 2014 · Current Opinion in Genetics & Development
  39. Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway
    Elizabeth E. Hoskins, Ranjaka W. Gunawardena, Kristen B. Habash, Trisha Michel Wise-Draper, M Jansen, Erik S. Knudsen, Susanne I. Wells · 2008 · Oncogene
  40. The Fanconi anemia pathway and ubiquitin
    Céline F. Jacquemont, Toshiyasu Taniguchi · 2007 · BMC Biochemistry
  41. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links
    Kimberly A. Rickman, Raymond J. Noonan, Francis P. Lach, Sunandini Sridhar, Anderson T. Wang, Avinash Abhyankar, Athena L. Huang, Michael C. Kelly, Arleen D. Auerbach, Agata Smogorzewska · 2020 · Genes & Development
  42. Requirement of Heterogeneous Nuclear Ribonucleoprotein C for BRCA Gene Expression and Homologous Recombination
    Rachel William Anantha, Allen L. Alcivar, Jianglin Ma, Hong Cai, Srilatha R. Simhadri, Jernej Ule, Julian König, Bing Xia · 2013 · PLoS ONE
  43. MRE11–RAD50–NBS1 is a critical regulator of FANCD2 stability and function during DNA double‐strand break repair
    Céline Lopez‐Roques, Yan Coulombe, Mathieu Delannoy, Julien Vignard, Simona Grossi, Isabelle Brodeur, Amélie Rodrigue, Jean Gautier, Alicja Z. Stasiak, Andrzej Stasiak et al. · 2009 · The EMBO Journal
  44. Hereditary breast cancer: From molecular pathology to tailored therapies
    Tan, D S P, Marchiò, C, Reis-Filho, J S · 2008 · Journal of Clinical Pathology
  45. Recent advances in understanding hematopoiesis in Fanconi Anemia
    Grover C. Bagby · 2018 · F1000Research
  46. The Fanconi anemia pathway and ICL repair: implications for cancer therapy
    Lily C. Wang, Jean Gautier · 2010 · Critical Reviews in Biochemistry and Molecular Biology
  47. HES1 is a novel interactor of the Fanconi anemia core complex
    Cedric Stevens Tremblay, Feng F. Huang, Ouassila Habi, Caroline Huard, Chantal Godin, Georges Lévesque, Madeleine Carreau · 2008 · Blood
  48. Ubiquitylation and the Fanconi anemia pathway
    Elizabeth Garner, Agata Smogorzewska · 2011 · FEBS Letters
  49. FANCD2 and DNA Damage
    Manoj K. Nepal, Raymond Che, Chi Ma, Jun Zhang, Peiwen Fei · 2017 · International Journal of Molecular Sciences
  50. PALB2 self-interaction controls homologous recombination
    Rémi Buisson, Jean‐Yves Masson · 2012 · Nucleic Acids Research
  51. Poly(ADP-Ribose) Mediates the BRCA2-Dependent Early DNA Damage Response
    Feng Zhang, Jiazhong Shi, Chunjing Bian, Xiaochun Yu · 2015 · Cell Reports
  52. Modification ofBRCA1-Associated Breast and Ovarian Cancer Risk byBRCA1-Interacting Genes
    Timothy Richard Rebbeck, Nandita Mitra, Susan M. Domchek, Fei Wan, Tara M. Friebel, Teo V. Tran, Christian Fridolin Singer, Muy-Kheng Maria Tea, Joanne L. Blum, Nadine Tung et al. · 2011 · Cancer Research
  53. Tissue specificity of DNA damage response and tumorigenesis
    Siman Sun, Michael D. Osterman, Mo Li · 2019 · Cancer Biology and Medicine
  54. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia
    Anna C. Pulliam, Samantha L. M. Ciccone, Grzegorz Nalepa, Xiaxin Li, Yue Cindy Si, Leticia Miravalle, Danielle Smith, Jin Yuan, Jingling Li, Praveen Anur et al. · 2010 · Blood
  55. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
    Ana Blanco, Miguel de la Hoya, Judith Balmañà, Teresa Ramón y Cajal, Àlex Teulé, María-Dolores Miramar, Eva Esteban, Mar Infante, Javier J. Benitez, Asunción Torres et al. · 2011 · Breast Cancer Research and Treatment
  56. MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress
    Jean‐Yves Bleuyard, Marjorie L. Fournier, Ryuichiro Nakato, Anthony M. Couturier, Yuki Katou, Christine Ralf, Svenja Hester, Daniel Dominguez, Daniela Rhodes, Timothy C. Humphrey et al. · 2017 · Proceedings of the National Academy of Sciences
  57. Holding All the Cards—How Fanconi Anemia Proteins Deal with Replication Stress and Preserve Genomic Stability
    Arindam Datta, Robert M. Brosh · 2019 · Genes
  58. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer
    Christian Bowman-Colin, Bing Xia, Samuel F. Bunting, Christiaan N. Klijn, Rinske Drost, Peter Bouwman, Laura Fineman, Xixi Chen, Aedín C. Culhane, Hong Cai et al. · 2013 · Proceedings of the National Academy of Sciences
  59. Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing
    Najim Ameziane, Daoud Sie, Stefan C. Dentro, Yavuz Ariyürek, Lianne Kerkhoven, Hans Joenje, Josephine C. Dorsman, Bauke Ylstra, Johan J. P. Gille, Erik A. Sistermans et al. · 2012 · Anemia
  60. The Role of Fanconi Anemia/BRCA Genes in Zebrafish Sex Determination
    Adriana Rodríguez‐Marí, John H. Postlethwait · 2011 · Methods in cell biology
  61. TNF-α signaling in Fanconi anemia
    Wei Du, Ozlem Erden, Qishen Pang · 2013 · Blood Cells Molecules and Diseases
  62. PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
    Srilatha R. Simhadri, Gabriele Vincelli, Yanying Huo, Sarah M. Misenko, Tzeh Keong Foo, Johanna K. Ahlskog, Claus Storgaard Sørensen, Greg G. Oakley, Shridar Ganesan, Samuel F. Bunting et al. · 2018 · Oncogene
  63. WAPL-Dependent Repair of Damaged DNA Replication Forks Underlies Oncogene-Induced Loss of Sister Chromatid Cohesion
    Bente Benedict, Janne J. M. van Schie, Anneke B. Oostra, Jesper A. Balk, Rob M.F. Wolthuis, Hein te Riele, Job de Lange · 2020 · Developmental Cell
  64. REV1 and DNA polymerase zeta in DNA interstrand crosslink repair
    Shilpy Sharma, Christine E. Canman · 2012 · Environmental and Molecular Mutagenesis
  65. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer
    Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Groß, Barbara Wappenschmidt, Christian Schem, Helmut Deißler, Nina Caroline Ditsch, Verena Gress, Marion B. Kiechle et al. · 2011 · Human Mutation
  66. ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair
    Jean‐Yves Bleuyard, Rémi Buisson, Jean‐Yves Masson, Fumiko Esashi · 2011 · EMBO Reports
  67. Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing
    Johan J. P. Gille, Karijn Floor, Lianne Kerkhoven, Najim Ameziane, Hans Joenje, Johan P. de Winter · 2012 · Anemia
  68. FANCP/SLX4
    Kelly E. Cybulski, Niall G. Howlett · 2011 · Cell Cycle
  69. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling
    Stefan Meyer, Marc D. Tischkowitz, Kate Chandler, Alan M. Gillespie, Jillian M. Birch, D. Gareth Evans · 2013 · Journal of Medical Genetics
  70. DNA double-strand break repair and development
    E R Phillips, Peter J. McKinnon · 2007 · Oncogene
  71. Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
    Pia Rantakari, Jenni Nikkilä, Heli Jokela, Roxana Ola, Katri Pylkäs, Heidi Lagerbohm, Kirsi Sainio, Matti H. POUTANEN, Robert Winqvist · 2010 · Human Molecular Genetics
  72. PALB2 mutations in German and Russian patients with bilateral breast cancer
    Natalia Viktorovna Bogdanova, Анна Петровна Соколенко, Aglaya G. Iyevleva, Светлана Николаевна Алексахина, Magda A Blaut, Michael Bremer, Hans Christiansen, Margret Rave‐Fränk, Thilo Dörk, Евгений Наумович Имянитов · 2010 · Breast Cancer Research and Treatment
  73. PALB2 sequence variants in young South African breast cancer patients
    Michelle D. Sluiter, Samantha Mynhardt, Elizabeth Jansen van Rensburg · 2009 · Familial Cancer
  74. PALB2 analysis in BRCA2-like families
    Muriel A. Adank, Saskia E. van Mil, J. J. P. Gille, Quinten Waisfisz, Hanne E.J. Meijers-Heijboer · 2010 · Breast Cancer Research and Treatment
  75. Guardians of the Genome: BRCA2 and Its Partners
    Hang Phuong Le, Wolf‐Dietrich Heyer, Jie Liu · 2021 · Genes
  76. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
    Ana Blanco, Miguel de la Hoya, Ana Osório, Orland Dı́ez, María Dolores Miramar, Mar Infante, Cristina Martínez-Bouzas, Asunción Torres, Adriana Lasa, Gemma Llort et al. · 2013 · PLoS ONE
  77. Genome‐wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co‐activation
    Andrea Gardini, David Baillat, Matteo Cesaroni, Ramin Shiekhattar · 2014 · The EMBO Journal
  78. Overview of the genetic basis toward early detection of breast cancer
    Sumadee De Silva, Kamani Hemamala Tennekoon, Eric Hamilton Karunanayake · 2019 · Breast Cancer Targets and Therapy
  79. High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Irene R. Rainville, Shanell Hatcher, Eric Rosenthal, Katie Larson, Ryan Bernhisel, Stephanie M. Meek, Heidi Gorringe, Erin Mundt, Susan Manley · 2020 · Breast Cancer Research and Treatment
  80. A never-ending story: the steadily growing family of the FA and FA-like genes
    Anna Gueiderikh, Filippo Rosselli, Januario B.C. Neto · 2017 · Genetics and Molecular Biology
  81. DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms
    Arwa A. Abugable, Julia L.M. Morris, Nelma M. Palminha, Ringaile Zaksauskaite, Swagat Ray, Sherif F. El‐Khamisy · 2019 · DNA repair
  82. A Boolean network model of the FA/BRCA pathway
    Alfredo Rodríguez, David Sosa, Leda Torres, Bertha Molina, Sara Frı́as, Luis Mendoza · 2012 · Bioinformatics
  83. A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
    Amélie Rodrigue, Guillaume Margaillan, Thiago T. Gomes, Yan Coulombe, Gemma Montalban, Simone da Costa e Silva Carvalho, Larissa Milano, Mandy Ducy, Giuliana De Gregoriis, Graham Dellaire et al. · 2019 · Nucleic Acids Research
  84. Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group
    Janna A. Hol, Rosalyn Jewell, Tanzina Chowdhury, Catriona Duncan, Kayo Nakata, Takaharu Oue, Marion Gauthier‐Villars, Annemieke Simone Littooij, Yasuhiko Kaneko, Norbert M. Graf et al. · 2021 · European Journal of Cancer
  85. Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
    Paul R. Andreassen, Keqin Ren · 2009 · Current Cancer Drug Targets
  86. A PALB2 germline mutation associated with hereditary breast cancer in Italy
    Laura Papi, Anna Laura Putignano, Caterina Congregati, Irene Piaceri, Ines Zanna, Francesco Sera, Doralba Morrone, Maurizio Genuardi, Domenico Palli · 2009 · Familial Cancer
  87. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
    Zhi Ling Teo, Daniel Jonathan Park, Elena Provenzano, Catherine Chatfield, Fabrice Odefrey, Tú Nguyen‐Dumont, kConFab, James G. Dowty, John Llewelyn Hopper, Ingrid Winship et al. · 2013 · Breast Cancer Research
  88. Fanconi anemia and solid malignancies in childhood: A national retrospective study
    Aurore Malric, Anne Sophie Defachelles, Thierry M Leblanc, Brigitte Lescoeur, Brigitte Lacour, Michel M. Peuchmaur, Claude‐Alain Maurage, Gaëlle Pierron, Delphine Guillemot, Catherine Dubois d’Enghien et al. · 2014 · Pediatric Blood & Cancer
  89. PALB2 and breast cancer: ready for clinical translation!
    Melissa C. Southey, Teo, Ingrid Winship · 2013 · The Application of Clinical Genetics
  90. BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges
    L. Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Isabelle Laure Ray-Coquard · 2024 · Frontiers in Oncology
  91. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
    Peter Bouwman, Rinske Drost, Christiaan N. Klijn, Mark Pieterse, Hanneke M.L. van der Gulden, Ji‐Ying Song, Károly Szuhai, Jos Jonkers · 2011 · The Journal of Pathology
  92. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer
    Yonglan Zheng, Jing Zhang, Kisha T Hope, Qun Niu, Dezheng Huo, Olufunmilayo Ibironke Olopade · 2010 · Breast Cancer Research and Treatment
  93. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
    Corine J. Hess, Najim Ameziane, Gerrit Jan Schuurhuis, Abdellatif Errami, Fedor Denkers, Gertjan J.L. Kaspers, Jacqueline J Cloos, Hans Joenje, Dirk Reinhardt, Gert Jan Ossenkoppele et al. · 2008 · PubMed Central
  94. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
    Νικολέτα Πουμπουρίδου, Christos Κroupis · 2012 · Clinical Chemistry and Laboratory Medicine (CCLM)
  95. Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated
    Femme Harinck, Irma Kluijt, Saskia E. van Mil, Quinten Waisfisz, Theo A.M. van Os, Cora M. Aalfs, Anja Wagner, Maran J.W. Olderode-Berends, Rolf H. Sijmons, Ernst Johan Kuipers et al. · 2011 · European Journal of Human Genetics
  96. Association of Common PALB2 Polymorphisms with Breast Cancer Risk: A Case-Control Study
    Peizhan Chen, Jie Liang, Zhanwei Wang, Xiaoyi Zhou, Lu Chen, Mian Li, Dong Xie, Zhibin Hu, Hongbing Shen, Hui Wang · 2008 · Clinical Cancer Research
  97. Fanconi anemia: at the Crossroads of DNA repair
    Julianna S. Deakyne, Alexander V. Mazin · 2011 · Biochemistry (Moscow)
  98. Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
    LifePool Investigators, Ella R. Thompson, Kylie L. Gorringe, Simone M. Rowley, Michelle W. Wong‐Brown, Simone McInerny, Na Li, Alison H. Trainer, Lisa Devereux, Maria Doyle et al. · 2015 · Breast Cancer Research
  99. DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein FANCD2
    Alexandra Sobeck, Stacie Stone, Maureen E. Hoatlin · 2007 · Molecular and Cellular Biology
  100. Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance
    Peter Horak, Joachim Weischenfeldt, Gunhild v. Amsberg, Burkhard Beyer, Andreas Schütte, Sebastian Uhrig, Laura Gieldon, Barbara Klink, Lars Feuerbach, Daniel Hübschmann et al. · 2019 · Molecular Case Studies